Correction to: Good response to tolvaptan shortens hospitalization in patients with congestive heart failure

被引:0
|
作者
Tomohito Kogure
Kentaro Jujo
Kazuyuki Hamada
Katsumi Saito
Nobuhisa Hagiwara
机构
[1] Tokyo Women’s Medical University,Department of Cardiology
[2] Nishiarai Heart Center Hospital,Department of Cardiology
来源
Heart and Vessels | 2018年 / 33卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
In the original publication of the article, the values of blood urea nitrogen (BUN) and plasma renin activity (PRA) have been published incorrectly and the corrected values are as follows.
引用
收藏
页码:384 / 384
相关论文
共 50 条
  • [41] Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction
    Nonin, Shinichi
    Iwata, Shinichi
    Ito, Asahiro
    Tamura, Soichiro
    Kitada, Ryoko
    Kawai, Yu
    Ishikawa, Sera
    Doi, Atsushi
    Hanatani, Akihisa
    Yoshiyama, Minoru
    IJC HEART & VASCULATURE, 2018, 21 : 69 - 73
  • [42] Right Ventricular Enlargement Predicts Responsiveness to Tolvaptan in Congestive Heart Failure Patients With Reduced Ejection Fraction
    Nonin, Shinichi
    Iwata, Shinichi
    Ito, Asahiro
    Tamura, Soichiro
    Kitada, Ryoko
    Kawai, Yu
    Ishikawa, Sera
    Doi, Atsushi
    Hanatani, Akihisa
    Yoshiyama, Minoru
    CIRCULATION, 2018, 138
  • [43] Efficacy and safety of intravenous OPC-61815 compared with oral tolvaptan in patients with congestive heart failure
    Sato, Naoki
    Uno, Shingo
    Kurita, Yuka
    Kim, Seongryul
    ESC HEART FAILURE, 2022, 9 (05): : 3275 - 3286
  • [44] Factors associated with readmission after long-term administration of tolvaptan in patients with congestive heart failure
    Yamashita, Shoko
    Takenaka, Miki
    Ohbayashi, Masayuki
    Kohyama, Noriko
    Kurihara, Tatsuya
    Sunaga, Tomiko
    Ishiguro, Hisaaki
    Kogo, Mari
    SINGAPORE MEDICAL JOURNAL, 2024, 65 (11) : 614 - 623
  • [45] The Effectiveness of Intermittent Administration of Tolvaptan for Idiopathic Dilated Cardiomyopathy with Congestive Heart Failure
    Takeuchi, Ryosuke
    Hosoya, Natsuko
    Kageyama, Shigetaka
    Yoshizaki, Toru
    Sakamoto, Atsushi
    Murata, Koichiro
    Nawada, Ryuzo
    Onodera, Tomoya
    Takizawa, Akinori
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S158 - S158
  • [46] Effect of tolvaptan administration on renal function in the acute phase of congestive heart failure
    Kawase, Y.
    Hata, R.
    Tada, T.
    Kadota, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 527 - 527
  • [47] Cerebrovascular response to carbon dioxide in patients with congestive heart failure
    Xie, AL
    Skatrud, JB
    Khayat, R
    Dempsey, JA
    Morgan, B
    Russell, D
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (03) : 371 - 378
  • [48] THE SYMPATHETIC RESPONSE TO EXERCISE IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    FRANCIS, GS
    GOLDSMITH, SR
    COHN, JN
    AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02): : 395 - 395
  • [49] Are Opioids Really Safe in Patients with Congestive Heart Failure? Response
    Dawson, Nancy
    PAIN MEDICINE, 2018, 19 (02) : 414 - 414
  • [50] RESPONSE TO MAGNESIUM SUPPLEMENTATION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    COSTELLO, RB
    DIBIANCO, R
    MOSERVEILLON, PB
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1994, 13 (05) : 522 - 523